
EyeNexo LLC (AKA: Eyephone LLC) Profile last edited on: 2/18/2025
CAGE: 78TU6
UEI: SCTQD2V8G8T5
Business Identifier: Improving access to quality eye care with smartphone apps Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 08
County: Suffolk
Congr. District: 08
County: Suffolk
Public Profile
Eyephone (being renamed EYENexo? (2020) is working on devleoping digital tools to improve quality eye care. Structured around improving access to accurate eye care through creative mobile app engineering and prototypes principals of the firm are leveraging established expertise in the eye care field to bring the power and the creativity of smartphone engineering and mobile technology to ophthalmic treatment. EyeTurn is an App for Android systems that measures the eyes alignment for patients with strabismus. Eyephone wants to increase accessibility to ophthalmic treatments by reducing prices and bringing innovative solutions to the doctors and patients. The goal of the company is to use the accessibility and power of the smartphones to provide fast and accurate measurements. The firm use smartphones to create a reliable network between expert eye doctors and patients via telemedicine.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2019 | 1 | NIH | $273,364 | |
Project Title: Head Mounted Smartphone System for Remote Treatment of Convergence Insufficiency | ||||
2018 | 2 | NIH | $1,164,798 | |
Project Title: Mobile Medical Application for Cost-Effective Strabismus Screening | ||||
0 | 1 | NIH | $245,148 | |
Project Title: Computer vision powered automation of rodent arena for assessment of early Alzheimer's disease. |
Key People / Management
Matteo Tomasi -- CEO
Gang Luo
David Titus -- VP of Business Development and Marketing
Gang Luo
David Titus -- VP of Business Development and Marketing
Company News
There are no news available.